ArticleBlood neoplasia2025
An antibody-drug conjugate targeting VpreB1 for the treatment of B-cell acute lymphoblastic leukemia.
Peter M Gordon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it